MedTrace Logo

Effect of Fecal Microbiota Transplantation in Slow Transit Constipation

NCT02301221 · Status: UNKNOWN · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2016-11-04

No results posted yet for this study

Summary

The purpose of this study is to evaluate the effect of fecal microbiota transplantation in adults with slow transit constipation.

Conditions

  • Slow Transit Constipation

Interventions

PROCEDURE

Fecal microbiota transplantation (FMT)

Standardized Frozen Fecal Microbiota will be infused via nasointestinal tube.

DRUG

Vancomycin and bowel lavage

An initial vancomycin regimen (500 mg orally two times per day for 3 days), followed by bowel lavage before the infusion of a solution of donor fecal microbiota.

Sponsors & Collaborators

  • Jinling Hospital, China

    lead OTHER

Principal Investigators

  • Ning Li, MD · Department of Generay Surgery, Jinling hosptal

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-03-31
Primary Completion
2016-03-31
Completion
2016-12-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02301221 on ClinicalTrials.gov